Piperacillin-d5 (CAS 61477-96-1 (unlabeled))
QUICK LINKS
Piperacillin-d5, is the labeled analogue of Piperacillin (sc-205807), an antibacterial agent that works by inhibiting the synthesis of the bacterial cell wall. It binds to penicillin-binding proteins (PBPs), which are enzymes involved in the synthesis of the cell wall. By inhibiting the activity of these enzymes, piperacillin prevents the cell wall from being built and the bacteria from growing and dividing. It has been used to study the mechanisms of bacterial resistance, the effects of antibiotics on bacterial growth, and the efficacy of antibiotic combinations. It may inhibit the growth of a variety of Gram-positive and Gram-negative bacteria, including Pseudomonas aeruginosa, Escherichia coli, and Enterococcus faecalis. It may act to have anti-inflammatory, antifungal, and antiviral effects.
Piperacillin-d5 (CAS 61477-96-1 (unlabeled)) References
- A simple ultra-high-performance liquid chromatography-high resolution mass spectrometry assay for the simultaneous quantification of 15 antibiotics in plasma. | Lefeuvre, S., et al. 2017. J Chromatogr B Analyt Technol Biomed Life Sci. 1065-1066: 50-58. PMID: 28946125
- Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses. | Schuster, C., et al. 2018. J Vis Exp.. PMID: 30222156
- Simultaneous Quantification of Nine Antimicrobials by LC-MS/MS for Therapeutic Drug Monitoring in Critically Ill Patients. | Neugebauer, S., et al. 2019. Ther Drug Monit. 41: 29-37. PMID: 30320624
- Augmented renal clearance is associated with inadequate antibiotic pharmacokinetic/pharmacodynamic target in Asian ICU population: a prospective observational study. | Wu, CC., et al. 2019. Infect Drug Resist. 12: 2531-2541. PMID: 31496765
- A 2D HPLC-MS/MS method for several antibiotics in blood plasma, plasma water, and diverse tissue samples. | Rehm, S. and Rentsch, KM. 2020. Anal Bioanal Chem. 412: 715-725. PMID: 31900530
- A liquid chromatography-tandem mass spectrometry platform for the routine therapeutic drug monitoring of 14 antibiotics: Application to critically ill pediatric patients. | Barco, S., et al. 2020. J Pharm Biomed Anal. 186: 113273. PMID: 32251979
- Stability and Validation of a High-Throughput LC-MS/MS Method for the Quantification of Cefepime, Meropenem, and Piperacillin and Tazobactam in Serum. | Bjergum, MW., et al. 2021. J Appl Lab Med. 6: 1202-1212. PMID: 34086904
- Reproducible Quantification of Unbound Fractions of Four Beta-Lactam Antibiotics: Ultrafiltration Versus Microdialysis of Spiked Healthy Donor Plasma. | Beijer, G., et al. 2023. Ther Drug Monit. 45: 45-54. PMID: 35971673
- An LC-MS/MS method for the simultaneous determination of 18 antibacterial drugs in human plasma and its application in therapeutic drug monitoring. | Lu, W., et al. 2022. Front Pharmacol. 13: 1044234. PMID: 36425576
- Population Pharmacokinetics of Piperacillin/Tazobactam Across the Adult Lifespan. | Hemmersbach-Miller, M., et al. 2023. Clin Pharmacokinet. 62: 127-139. PMID: 36633812
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Piperacillin-d5, 1 mg | sc-476272 | 1 mg | $505.00 | |||
Piperacillin-d5, 10 mg | sc-476272A | 10 mg | $2515.00 |